Vanguard Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-54,889,560
Closed -$5.45B 4211
2019
Q3
$5.45B Buy
54,889,560
+773,825
+1% +$73.5M 0.2% 91
2019
Q2
$5B Buy
54,115,735
+929,823
+2% +$88.3M 0.19% 93
2019
Q1
$5.02B Buy
53,185,912
+628,729
+1% +$55M 0.2% 90
2018
Q4
$3.37B Buy
52,557,183
+904,021
+2% +$66.7M 0.15% 120
2018
Q3
$4.62B Sell
51,653,162
-403,166
-0.8% -$35.6M 0.18% 96
2018
Q2
$4.13B Sell
52,056,328
-1,839,087
-3% -$153M 0.17% 106
2018
Q1
$4.81B Sell
53,895,415
-1,606,752
-3% -$154M 0.21% 84
2017
Q4
$5.79B Buy
55,502,167
+991,024
+2% +$112M 0.25% 67
2017
Q3
$7.95B Buy
54,511,143
+983,933
+2% +$134M 0.37% 43
2017
Q2
$6.95B Buy
53,527,210
+1,610,056
+3% +$197M 0.34% 43
2017
Q1
$6.46B Buy
51,917,154
+2,067,605
+4% +$247M 0.33% 44
2016
Q4
$5.77B Buy
49,849,549
+984,196
+2% +$110M 0.32% 48
2016
Q3
$5.11B Buy
48,865,353
+1,031,636
+2% +$112M 0.3% 53
2016
Q2
$4.72B Buy
47,833,717
+395,600
+0.8% +$40.9M 0.29% 59
2016
Q1
$4.75B Buy
47,438,117
+1,039,793
+2% +$107M 0.31% 56
2015
Q4
$5.56B Buy
46,398,324
+808,611
+2% +$93.6M 0.37% 46
2015
Q3
$4.93B Buy
45,589,713
+488,767
+1% +$60.7M 0.36% 49
2015
Q2
$5.22B Buy
45,100,946
+336,699
+0.8% +$38.5M 0.35% 49
2015
Q1
$5.16B Buy
44,764,247
+1,809,920
+4% +$216M 0.35% 50
2014
Q4
$4.8B Buy
42,954,327
+1,097,085
+3% +$116M 0.35% 47
2014
Q3
$3.97B Buy
41,857,242
+815,635
+2% +$73.6M 0.31% 51
2014
Q2
$3.52B Sell
41,041,607
-192,429
-0.5% -$14.6M 0.28% 61
2014
Q1
$2.88B Buy
41,234,036
+533,186
+1% +$42.2M 0.24% 76
2013
Q4
$3.44B Buy
40,700,850
+666,230
+2% +$52.7M 0.3% 56
2013
Q3
$3.08B Buy
40,034,620
+136,578
+0.3% +$9.57M 0.3% 57
2013
Q2
$2.33B Buy
+39,898,042
New +$2.4B 0.24% 73

Other funds holding CELG